SUN Pharmaceutical Industries Limited — Vildagliptin Exporter Profile
Indian Pharmaceutical Exporter · #7 for Vildagliptin · $409.8K export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #7 Indian exporter of Vildagliptin with $409.8K in export value and 31 verified shipments. SUN Pharmaceutical Industries Limited holds a 4.0% market share in Vildagliptin exports across 5 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Vildagliptin Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Vildagliptin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $167.3K | 17 | 40.8% |
| SOUTH AFRICA | $139.3K | 9 | 34.0% |
| MALAYSIA | $68.8K | 3 | 16.8% |
| FRANCE | $23.2K | 1 | 5.7% |
| ZIMBABWE | $11.2K | 1 | 2.7% |
SUN Pharmaceutical Industries Limited exports Vildagliptin to 5 countries. The largest destination is BRAZIL accounting for 40.8% of SUN Pharmaceutical Industries Limited's Vildagliptin shipments, followed by SOUTH AFRICA (34.0%) and MALAYSIA (16.8%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Vildagliptin from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| RANBAXY PHARMACEUTICALS PTY LTD., | SOUTH AFRICA | $112.1K | 8 |
| RANBAXY FARMACEUTICA LTDA | BRAZIL | $89.3K | 8 |
| RANBAXY FARMACEUTICA LTDA : | BRAZIL | $77.9K | 3 |
| RANBAXY(MALAYSIA)SDN.BHD.. | MALAYSIA | $44.8K | 2 |
| M S RANBAXY PHARMACEUTICALS PTY LT | SOUTH AFRICA | $27.2K | 1 |
| RANBAXY MALAYSIA SDN BHD | MALAYSIA | $24.0K | 1 |
| PLANET PHARMA | FRANCE | $23.2K | 1 |
| M/S. PHARMACEUTICAL & CHEMICAL | ZIMBABWE | $11.2K | 1 |
| SUN FARMACEUTICA DO BRAZIL LTDA | BRAZIL | $73 | 6 |
SUN Pharmaceutical Industries Limited supplies Vildagliptin to 9 buyers globally. The largest buyer is RANBAXY PHARMACEUTICALS PTY LTD., (SOUTH AFRICA), followed by RANBAXY FARMACEUTICA LTDA (BRAZIL) and RANBAXY FARMACEUTICA LTDA : (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Vildagliptin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $7.5M worth of Vildagliptin through 1,149 shipments from 178 suppliers to 87 countries, serving 304 buyers globally. SUN Pharmaceutical Industries Limited contributes $409.8K to this total, accounting for 4.0% of India's Vildagliptin exports. SUN Pharmaceutical Industries Limited ships Vildagliptin to 5 countries through 9 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Vildagliptin Exports?
SUN Pharmaceutical Industries Limited's average Vildagliptin shipment value is $13.2K per consignment, based on 31 shipments totaling $409.8K. The largest destination is BRAZIL (40.8% of SUN Pharmaceutical Industries Limited's Vildagliptin exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Vildagliptin Exporters?
SUN Pharmaceutical Industries Limited ranks #7 among 178 Indian Vildagliptin exporters with a 4.0% market share. The top 3 exporters are AJANTA PHARMA LIMITED ($1.8M), CADILA PHARMACEUTICALS LIMITED ($1.0M), INTAS PHARMACEUTICALS LIMITED ($996.7K). SUN Pharmaceutical Industries Limited processed 31 shipments to 5 destination countries.
What Vildagliptin Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VILDAGLIPTIN TAB 50MG 6X10B BR EACH CONTAINS : VILDAGLIPTIN TAB 50MG PACK : Box60s | $77.9K | 3 |
| VILDAGLIPTIN TABLETS 50MG (EACH TABLETSCONTAINS: VILDAGLIPTIN 50MG) [13507 PACKS X60'S] B NO.PTF0631A, PTF0632A, PTF063 | $49.2K | 3 |
| SUCRALO TAB 50MG CONTAINS VILDAGLIPTIN TAB SAP CODE : 1163494 BATCH : PTE5048A MFD : 12.12.2023 EXP : 30.11.2025NOS | $44.8K | 2 |
| VILEPTIN CO TABLETS 50/1000MG (EACH TABLET CONTAINS: VILDAGLIPTIN 50MG + METFORMIN HCL 1000MG) [7477 PACK X 6X10'S] (BAT | $32.8K | 1 |
| VILEPTIN CO TABS 50/1000MG E.TAB CONT.VILDAGLIPTIN 50MG,METFORMIN HCL 1000MG,Batch:PTG0335A,PTG0336A, PTG0337A,PTG0520AP | $31.1K | 1 |
| VILEPTIN CO TABS 50 1000MG EACH TAB CONTAINS VILDAGLIPTIN 50MG METFORMIN HCL 1000MG PACK SP Batch PTG1229A PTG1209 | $27.2K | 1 |
| VILDAGLIPTIN TAB 50MG 6X10B BR EACH CONTAINS VILDAGLIPTIN TAB 50MG PACK Box60s | $25.1K | 1 |
| SUCRALO TAB 50MG VILDAGLIPTIN TABLETS 50 MG BATCH NO PTG1716A MFG DT 04 2025EXP DT 03 2027 | $24.0K | 1 |
| VIDAGLIN TAB 50MG 3X10B FWA (VILDAGLIPTIN TABLETS) PACK: Box3x10s | $23.2K | 1 |
| VILEPTIN CO TABS 50/1000MG EACH TAB CONTAINS VILDAGLIPTIN 50MG,METFORMIN HCL 1000MG PACK : SP | $16.7K | 2 |
SUN Pharmaceutical Industries Limited exports 23 distinct Vildagliptin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VILDAGLIPTIN TAB 50MG 6X10B BR EACH CONTAINS : VILDAGLIPTIN with 3 shipments worth $77.9K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Vildagliptin to Key Markets
What SUN Pharmaceutical Industries Limited must comply with to export Vildagliptin to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Vildagliptin Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | EMCURE PHARMACEUTICALS LIMITED | $984.8K | 64 | 4 | $15.4K |
| 6 | MICRO LABS LIMITED | $494.8K | 15 | 8 | $33.0K |
| 7 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $409.8K | 31 | 5 | $13.2K |
| 8 | MACLEODS PHARMACEUTICALS LTD | $349.5K | 14 | 2 | $25.0K |
| 9 | AET LABORATORIES PRIVATE LIMITED | $331.5K | 8 | 2 | $41.4K |
SUN Pharmaceutical Industries Limited ranks #7 among 178 Indian Vildagliptin exporters. Average shipment value of $13.2K compared to the market average of $42.0K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Vildagliptin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 165 | 14.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 127 | 11.1% |
| DELHI AIR | 71 | 6.2% |
| NHAVA SHEVA SEA (INNSA1) | 59 | 5.1% |
| DELHI AIR CARGO ACC (INDEL4) | 59 | 5.1% |
| Bombay Air | 57 | 5.0% |
| JNPT/ NHAVA SHEVA SEA | 46 | 4.0% |
| MUNDRA SEA (INMUN1) | 43 | 3.7% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Vildagliptin Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Vildagliptin, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vildagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vildagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 31 individual customs records matching SUN Pharmaceutical Industries Limited exporting Vildagliptin, covering 23 formulations to 5 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 87+ countries, 304+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vildagliptin Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Vildagliptin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Vildagliptin Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vildagliptin. For current shipment-level data, contact TransData Nexus.